Senior insider sale
SVP & General Counsel at NEKTAR THERAPEUTICS — senior position signals high conviction
$37.1K
630.00 shares
What this filing means
WILSON MARK ANDREW plans to sell 630.00 shares of NEKTAR THERAPEUTICS valued at approximately $37.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/25/2025ACC: 0001959173-25-007275
Officer· SVP & General Counsel
Since Mar 2020
630.00
Shares to sell
$37.1K
Approx. market value
630.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
11/21/2025
630.00Total acquired630.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/21/2025 | Restricted Stock Vesting Compensation | 630.00 | — |
| Total | 630.00 | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
630.00
Market value
$37.1K
11/25/2025
Total
Units
630.00
Value
$37.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
11/25/2025 | 630.00 | $37.1K | NASDAQ | Planned |
| Total | 630.00 | $37.1K | ||